MedPath

Northwestern University Human Resources

Northwestern University Human Resources logo
🇺🇸United States
Ownership
Private
Established
1851-01-28
Employees
5K
Market Cap
-
Website
https://www.venturecat.northwestern.edu

Alpha-lipoic Acid in Patients at Risk for Paclitaxel Induced Neuropathy

Phase 1
Completed
Conditions
Peripheral Neuropathy
Interventions
First Posted Date
2011-03-11
Last Posted Date
2014-10-02
Lead Sponsor
Northwestern University
Target Recruit Count
9
Registration Number
NCT01313117
Locations
🇺🇸

Northwestern Medical Faculty Foundation, Chicago, Illinois, United States

Non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Refractory Crohn's Disease

Phase 1
Terminated
Conditions
Crohn's Disease
Interventions
Biological: Allogeneic Stem Cell Therapy
First Posted Date
2011-02-02
Last Posted Date
2018-08-06
Lead Sponsor
Northwestern University
Target Recruit Count
9
Registration Number
NCT01288053
Locations
🇺🇸

Northwestern University, Chicago, Illinois, United States

Tailored Communication to Reduce Cardiovascular Risk

Not Applicable
Completed
Conditions
Hypertension
Hypercholesterolemia
Coronary Artery Disease
Dyslipidemia
Interventions
Behavioral: Direct-to-patient tailored cardiovascular risk message system
First Posted Date
2011-01-31
Last Posted Date
2015-02-09
Lead Sponsor
Northwestern University
Target Recruit Count
464
Registration Number
NCT01286311
Locations
🇺🇸

Northwestern Medical Faculty Foundation General Internal Medicine Ambulatory Clinic, Chicago, Illinois, United States

Hematopoietic Stem Cell Support Versus Insulin in T1D

Phase 1
Withdrawn
Conditions
Diabetes Mellitus, Type 1
Interventions
Biological: Autologous Hematopoietic Stem Cell Transplantation
Drug: intensive insulin therapy
First Posted Date
2011-01-28
Last Posted Date
2015-08-21
Lead Sponsor
Northwestern University
Registration Number
NCT01285934

Comparing the Pain Experience Between Patients Who Have and Who Have Not Undergone Dermatologic Procedures

Not Applicable
Completed
Conditions
Pain
Interventions
Device: Thermage
Other: Needle Application
Device: VBeam Laser
Device: Ulthera
First Posted Date
2011-01-28
Last Posted Date
2021-12-06
Lead Sponsor
Northwestern University
Target Recruit Count
20
Registration Number
NCT01285947
Locations
🇺🇸

Northwestern University Department of Dermatology, Chicago, Illinois, United States

Treatment of Keratosis Pilaris With 810 nm Diode Laser

Not Applicable
Completed
Conditions
Keratosis Pilaris (KP)
Interventions
Device: Diode Laser
First Posted Date
2011-01-24
Last Posted Date
2021-12-06
Lead Sponsor
Northwestern University
Target Recruit Count
23
Registration Number
NCT01281644
Locations
🇺🇸

Northwestern University, Chicago, Illinois, United States

Reduction of IgE Antibody in Human Allergic Subjects

Phase 1
Completed
Conditions
Seasonal Allergic Rhinitis
Interventions
Biological: substance P
Biological: substance P injections
First Posted Date
2011-01-20
Last Posted Date
2018-08-21
Lead Sponsor
Northwestern University
Target Recruit Count
40
Registration Number
NCT01280149
Locations
🇺🇸

Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States

Infrapatellar Nerve Block for Post-operative Knee Arthroscopy Pain Control

Phase 4
Completed
Conditions
Internal Derangement of Knee
Interventions
Drug: Normal Saline
Drug: 0.25% Bupivacaine
First Posted Date
2011-01-19
Last Posted Date
2014-05-12
Lead Sponsor
Northwestern University
Target Recruit Count
68
Registration Number
NCT01279447
Locations
🇺🇸

Olson Surgical Pavilion, Chicago, Illinois, United States

Botox and Suction-Curettage for Treatment of Excessive Underarm Sweating (Axillary Hyperhidrosis)

Not Applicable
Completed
Conditions
Axillary Hyperhidrosis
Interventions
Device: Suction-Curettage
Drug: Botulinum Toxin Type A
First Posted Date
2011-01-11
Last Posted Date
2021-12-06
Lead Sponsor
Northwestern University
Target Recruit Count
20
Registration Number
NCT01274611
Locations
🇺🇸

Northwestern University Feinberg School of Medicine, Department of Dermatology, Chicago, Illinois, United States

The Use of Bupivacaine and Ropivacaine for Sciatic Nerve Block

Phase 4
Completed
Conditions
The Duration of Motor Block May Vary Between 12-36 Hrs
Interventions
First Posted Date
2011-01-10
Last Posted Date
2017-04-06
Lead Sponsor
Northwestern University
Target Recruit Count
142
Registration Number
NCT01272921
Locations
🇺🇸

Northwestern University, Feingberg School of Medicine, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath